GENESISCS COMPONENT CONCENTRATING SYSTEM— 510(k) K070666
Substantially EquivalentPerfusion Partners & Assoc., Inc.
FDA 510(k) clearance K070666 for GENESISCS COMPONENT CONCENTRATING SYSTEM, Substantially Equivalent on 2007-06-20. Applicant: Perfusion Partners & Assoc., Inc.. Device class: 1.
Clearance details
- Applicant
- Perfusion Partners & Assoc., Inc.
- Product code
- Code JQC
- Device class
- Class 1
- Regulation
- 21 CFR 862.2050
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Pahrump, NV, US
Recent devices under product code JQC
view all- K183205 — PureBMC SupraPhysiologic Concentrating System 30 mL System, PureBMC SupraPhysiologic Concentrating System 60 mL System, PureBMC SupraPhysiologic Concentrating System 120 mL System
- K103340 — SMARTPREP2 BMAC SYSTEM, SMARTPREP PLATELET CONCENTRATION SYSTEM
- K081345 — AXP PLATFORM MARROW XPRESS SYSTEM MODEL 8-5137, 8-5138, 8-5139, 8-5140 (PRIMARY)
- K071934 — MARROWSTIM CONCENTRATION KIT AND MARROWSTIM MINI CONCENTRATION KIT
- K052925 — SMARTPREP2 CENTRIFUGE SYSTEM
More clearances from Perfusion Partners & Assoc., Inc.
view allAdverse events under product code JQC
product code JQC- Other
- 1
- Total
- 1
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.